Our preliminary results demonstrate potential to treat the following conditions:

Diabetic Retinopathy

Diabetic retinopathy is a leading cause of blindness in diabetic patients. Early detection and treatment are critical for prevention of vision loss and blindness.

Macular Degeneration

Age Related Macular Degeneration (ARMD) is a major cause of blindness worldwide and is the leading cause of vision loss and blindness for Americans aged 65 years and older.


Our platform technology has potential to treat additional conditions and diseases.